one.bio

About:

one.bio is an emerging biotechnology spinout from UC Davis that creates ingredients for food and biopharmaceutical applications.

Website: https://www.one.bio/

Top Investors: Bill & Melinda Gates Foundation, Seventure Partners, Collaborative Fund, Acre Venture Partners, iSelect Fund

Description:

one.bio is a fast-paced, emerging biotechnology spinout from UC Davis creating ingredients for food and biopharmaceutical applications. We use proprietary technology to create novel oligosaccharides from natural products, with a focus on producing ingredients that beneficially modulate the microbiome and immune function.

Total Funding Amount:

$17M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Sacramento, California, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)one.bio

Founders:

Bruce German, Carlito Lebrilla, David Mills, Matt Barnard, Matthew Amicucci

Number of Employees:

11-50

Last Funding Date:

2022-04-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai